Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers
- PMID: 38127471
- PMCID: PMC10722947
- DOI: 10.1177/20499361231214901
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers
Abstract
Background: Outpatient Parenteral Antimicrobial Therapy (OPAT) is considered a patient-friendly and cost-effective practice. Patients in the OPAT service can be at risk for developing adverse events. Due to extensive variations in practice, guidelines have been developed to minimize the risks.
Objectives: In this first worldwide survey on OPAT, we explored the current OPAT services around the world, adherence to recommendations and identified best practices and challenges from different perspectives.
Methods: An e-survey was conducted and consisted of questions about demographics, characteristics of the OPAT service, role of pharmacy, future developments, and respondents' views on improvements as well as best practices.
Results: A total of 126 responses from 28 countries were included. Seventy-eight percent (78%) of the respondents stated that their facility provides antimicrobial therapy in the outpatient setting, whereas 22% did not. Forty-two percent (42%) of the hospitals with OPAT services had a specialized OPAT service, while 14% lacked specialized services and 22% had a partially specialized team in place. In facilities with a specialized OPAT service, the number of mandatory infectious disease (ID) consultations before discharge and clinical monitoring by an ID specialist or OPAT team member, the frequency of monitoring, and the availability of an OPAT registry were higher. A multidisciplinary team's presence was commonly noted as best practices. On the other hand, respondents experienced difficulties with reimbursement and lack of standardization in the screening, follow-up and monitoring of patients.
Conclusion: This survey provides a better understanding of the implementation and practices of OPAT services globally and describes best practices and the challenges from different professionals.
Keywords: OPAT; Outpatient Parenteral Antimicrobial Therapy; antibiotics; infectious diseases; patient safety; survey.
Plain language summary
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.
Background: Outpatient parenteral antimicrobial therapy (OPAT) is defined as ‘the administration of parenteral antimicrobial therapy in at least 2 doses on different days without intervening hospitalization’National and continental studies show a great proportion of unregulated OPAT services with the implementation of a specialized OPAT team varying extensively.Besides the perspectives of infectious disease specialists, the perspectives of other healthcare workers involved with OPAT is under investigated.
Method: An electronic e-survey was conducted with questions about demographics, characteristics of OPAT service, the role of the pharmacy in OPAT, future developments and best-practices and challenges.
Results: OPAT services have a high global adoption rate of 78%, however only 42% of healthcare facilities offer formal OPAT servicesFacilities with formal OPAT services have higher requirements for infectious disease consultation before discharge, clinical monitoring by an OPAT team member, monitoring frequency, and availability of an OPAT registryBest practices include a multidisciplinary OPAT team and the use of elastomer pumpsCommon challenges in OPAT involve reimbursement issues and lack of standardization in patient screening, follow-up, and monitoring.
Conclusion: This is the first worldwide study exploring the implementation of OPAT services and perspectives of different professionals.
© The Author(s), 2023.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures


Similar articles
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).Infect Dis (Lond). 2015 Jan;47(1):39-45. doi: 10.3109/00365548.2014.967290. Epub 2014 Nov 21. Infect Dis (Lond). 2015. PMID: 25415655
-
Perspectives of United States-based Infectious Diseases Physicians on Outpatient Parenteral Antimicrobial Therapy Practice.Open Forum Infect Dis. 2019 Oct 1;6(10):ofz363. doi: 10.1093/ofid/ofz363. Open Forum Infect Dis. 2019. PMID: 31429872 Free PMC article.
-
Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.J Pharm Pract. 2015 Oct;28(5):462-8. doi: 10.1177/0897190014544786. Epub 2014 Aug 8. J Pharm Pract. 2015. PMID: 25107418
-
Barriers and facilitators for the implementation and expansion of outpatient parenteral antimicrobial therapy: a systematic review.J Hosp Infect. 2024 May;147:1-16. doi: 10.1016/j.jhin.2024.02.006. Epub 2024 Feb 27. J Hosp Infect. 2024. PMID: 38423135
Cited by
-
Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey.JAC Antimicrob Resist. 2025 May 27;7(3):dlaf075. doi: 10.1093/jacamr/dlaf075. eCollection 2025 Jun. JAC Antimicrob Resist. 2025. PMID: 40433448 Free PMC article.
References
-
- Norris AH, Shrestha NK, Allison GM, et al.. 2018 Infectious diseases society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 2019; 68: 1–4. - PubMed
-
- Chapman AL. Outpatient parenteral antimicrobial therapy. BMJ 2013; 346: f1585. - PubMed
-
- Quintens C, Steffens E, Jacobs K, et al.. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program. Infection 2020; 48: 357–366. - PubMed
-
- Wolter JM, Cagney RA, McCormack JG. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. J Infect 2004; 48: 263–268. - PubMed
LinkOut - more resources
Full Text Sources